University of Illinois, Chicago

NURS 531

Chapter 35: The reproductive system

MULTIPLE CHOICE

1)The expression of estrogen receptors in the mammary gland is increased by

1. oxytocin
2. progesterone
3. prolactin
4. gonadotrophins
5. androgens

2.    The secretion of progesterone from the corpus luteum is primarily stimulated by

1. follicle-stimulating hormone
2. luteinizing hormone
3. estrogen
4. prolactin
5. oxytocin

3.    Compared to the combination estrogen-progestogen contraceptive, the progestogen-only pill is more likely to

1. cause hypertension
2. prevent conception
3. cause breast cancer
4. cause myocardial infarction
5. produce irregular bleeding

4.    Administration of sildenafil leads to

1. activation of guanylate cyclase
2. inhibition of guanylate cyclase

3. activation of phosphodiesterase V
4. inhibition of phosphodiesterase V
5. release of nitric oxide

5.    In the estrogen-progestogen contraceptive pill, the estrogen component acts primarily by inhibiting

1. secretion of LH
2. secretion of FSH
3. ovulation
4. passage of sperm
5. mucus secretion

6.    The prevention and treatment of postpartum hemorrhage may include injections of

1. estrogen
2. progestogen
3. oxytocin
4. ritodrine
5. prolactin

7.    The benefits of using estrogen-progestogen contraceptive pills include

1. decreased risk of hypertension
2. improved glucose tolerance
3. decreased risk of breast cancer
4. decreased menstrual irregularities
5. decreased risk of stroke

8.    The use of atosiban to delay premature labor is based on its ability to

1. block b2-adrenoceptors
2. activate b2-adrenoceptors
3. block progesterone receptors
4. activate progesterone receptors
5. block oxytocin receptors

9.    When finasteride is used in treating benign prostatic hypertrophy, it acts by

1. blocking androgen receptors
2. inhibiting gonadotrophin secretion
3. inhibiting 5a-reductase
4. inhibiting testosterone secretion
5. blocking a1 adrenoceptors

10.   The interaction between nitroglycerin and sildenafil results from the